Cargando…
Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic lower urinary tract condition. Patients with IC/BPS suffer from debilitating pain and urinary urgency. The underlying etiology of IC/BPS is unknown and as such current treatments are mostly symptomatic with no real cure. Many theories...
Autores principales: | Taidi, Zhinoos, Mansfield, Kylie J., Bates, Lucy, Sana-Ur-Rehman, Hafiz, Liu, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bladder
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401983/ https://www.ncbi.nlm.nih.gov/pubmed/32775480 http://dx.doi.org/10.14440/bladder.2019.789 |
Ejemplares similares
-
Protective Effect of Purinergic P2X7 Receptor Inhibition on Acrolein-Induced Urothelial Cell Damage
por: Taidi, Zhinoos, et al.
Publicado: (2022) -
P2X7 Receptor Blockade Protects Against Acrolein-Induced Bladder Damage: A Potential New Therapeutic Approach for the Treatment of Bladder Inflammatory Diseases
por: Taidi, Zhinoos, et al.
Publicado: (2021) -
Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis
por: Kullmann, F. Aura, et al.
Publicado: (2018) -
The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder
por: Chung, Maurice K., et al.
Publicado: (2010) -
Increased bladder permeability in interstitial cystitis/painful bladder syndrome
por: Hurst, Robert E., et al.
Publicado: (2015)